FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
Revlimid (lenalidomide) Information
This new molecular entity is used to treat Myelodysplastic Syndrome (MDS)
Back to Top Back to Drug Index
PDF requires the free Adobe Acrobat Reader
Date created: December 23, 2005, updated February 27, 2006
CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page
FDA/Center for Drug Evaluation and Research